Literature DB >> 23871891

Neurocysticercosis in Europe: Still a public health concern not only for imported cases.

S Fabiani1, F Bruschi.   

Abstract

Neurocysticercosis (NCC), a parasitic disease caused by the larvae of the cestode Taenia solium, is the most frequent parasitic disease of the central nervous system (CNS) in the world and the leading cause of secondary epilepsy in Central and South America, East and South Asia, and sub-Saharan Africa. It is endemic in many low- and middle-income countries of the world. Due to increased travels and immigration, NCC may be diagnosed also in non-endemic areas. In fact, tapeworm carriers from endemic zones can transmit infection to other citizens or arrive already suffering NCC. This phenomenon, occurred first in USA during the last 30 years, has been also observed in Europe, as well as in Australia, Canada, Israel, Japan and Muslim countries of the Arab World. Actually, concerning Europe, although, in some areas only few cases have been described, nevertheless the prevalence of NCC may be considered increasing, especially in Spain and Portugal. We reviewed the literature on the burden of NCC in Europe, by a search of PubMed regarding papers from 1970 to present. We only considered on PubMed published and available papers in English, French, Italian, and Spanish, the languages understood by the authors. One hundred seventy six cases of NCC have been reported in seventeen European countries (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Netherlands, Sweden, United Kingdom, and Croatia, Norway, Switzerland). A particular epidemic situation is present in Spain and Portugal. In fact, we collected data that show, in Spain, an increasing incidence both in immigrated patients and in those which were born in certain Spanish geographical areas and, in Portugal, prevalence similar to that observed in endemic areas. Globally, it is clear that as a result of increased migrations and travels from endemic regions, NCC is becoming an emerging public health problem in high-income countries, particularly affecting communities where hygiene conditions are poor and sub-sequentially the parasite can spread from human to human through eggs even in absence of a travel to the tropics. NCC is a preventable disease, it derives that it's important to acquire a great consciousness of the epidemiology and to implement accurate surveillance systems.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autochthonous cases; CNS; Epidemiology; Europe; Imported cases; NCC; Neurocysticercosis; central nervous system; neurocysticercosis

Mesh:

Year:  2013        PMID: 23871891     DOI: 10.1016/j.actatropica.2013.06.020

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  24 in total

Review 1.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

2.  Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis.

Authors:  A Arce-Sillas; D D Álvarez-Luquín; G Cárdenas; D Casanova-Hernández; G Fragoso; M Hernández; J V Proaño Narváez; F García-Vázquez; A Fleury; E Sciutto; L Adalid-Peralta
Journal:  Clin Exp Immunol       Date:  2015-11-11       Impact factor: 4.330

3.  Prevalence of cysticercosis in Estonian pigs and cattle.

Authors:  Elisabeth Dorbek-Kolin; Tuuli Åhlberg; Lea Tummeleht; Dennis Tappe; Maria Vang Johansen; Brian Lassen
Journal:  Parasitol Res       Date:  2017-12-11       Impact factor: 2.289

4.  Cerebral Cysticercosis Presenting With Recurrent Epileptic Seizures.

Authors:  Pham Hong Van; Nguyen Quang Thieu; Cao Ba Loi; Ngo Minh Xuan; Huynh Quang Huy
Journal:  Cureus       Date:  2020-05-16

5.  Development of a dose-response model for porcine cysticercosis.

Authors:  Daniel A Andrade-Mogrovejo; Eloy Gonzales-Gustavson; Ana C Ho-Palma; Joaquín M Prada; Gabrielle Bonnet; Francesco Pizzitutti; Luis A Gomez-Puerta; Gianfranco Arroyo; Seth E O'Neal; Hector H Garcia; Javier Guitian; Armando Gonzalez
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

6.  Collaborative Studies for the Detection of Taenia spp. Infections in Humans within CYSTINET, the European Network on Taeniosis/Cysticercosis.

Authors:  María Ángeles Gómez-Morales; Patrizio Pezzotti; Alessandra Ludovisi; Belgees Boufana; Pierre Dorny; Titia Kortbeek; Joachim Blocher; Veronika Schmidt; Marco Amati; Sarah Gabriël; Edoardo Pozio; Andrea Sylvia Winkler; The Ring Trial Participants
Journal:  Microorganisms       Date:  2021-05-29

Review 7.  Genetic Diversity of Taenia solium and its Relation to Clinical Presentation of Cysticercosis.

Authors:  Akira Ito; Christine M Budke
Journal:  Yale J Biol Med       Date:  2021-06-30

8.  Human cysticercosis in Portugal: long gone or still contemporary?

Authors:  M Vilhena; A G Fonseca; S Dias; J Marques DA Silva; J Torgal
Journal:  Epidemiol Infect       Date:  2016-10-04       Impact factor: 4.434

9.  Mortality in Parenchymal and Subarachnoid Neurocysticercosis.

Authors:  Jesus Abanto; Daniel Blanco; Herbert Saavedra; Isidro Gonzales; Diego Siu; E Javier Pretell; Javier A Bustos; Hector H Garcia
Journal:  Am J Trop Med Hyg       Date:  2021-07-07       Impact factor: 3.707

10.  Risk factors and prevalence of taeniasis among the Karen people of Tha Song Yang District, Tak Province, Thailand.

Authors:  Teera Kusolsuk; Kittipong Chaisiri; Akkarin Poodeepiyasawad; Surapol Sa-Nguankiat; Nirundorn Homsuwan; Tetsuya Yanagida; Munehiro Okamoto; Dorn Watthanakulpanich; Jitra Waikagul; Paron Dekumyoy; Chalit Komalamisra; Akira Ito
Journal:  Parasite       Date:  2021-06-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.